ORAL SCAN: Effects Of The Oral JAK Inhibitor Tofacitinib In Combination With Methotrexate On Patient Reported Outcomes In a 24-Month Phase 3 Trial Of Active Rheumatoid Arthritis

被引：0
|
作者：
Strand, V. [1 ]
van der Heijde, D. [2 ]
Zerbini, C. A. F. [3 ]
Connell, C. A. [4 ]
Gruben, D. [4 ]
Riese, R. [4 ]
Wallenstein, G. [4 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Ctr Paulista Invest Clin, Sao Paulo, Brazil
[4] Pfizer Inc, Groton, CT 06340 USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2334
引用
收藏
页码：S996 / S997
页数：2
相关论文
共 50 条
  • [31] Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
    Vibeke Strand
    Mark Kosinski
    Chieh-I Chen
    George Joseph
    Regina Rendas-Baum
    Neil M. H. Graham
    Hubert van Hoogstraten
    Martha Bayliss
    Chunpeng Fan
    Tom Huizinga
    Mark C. Genovese
    Arthritis Research & Therapy, 18
  • [32] Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial
    Strand, Vibeke
    Kosinski, Mark
    Chen, Chieh-I
    Joseph, George
    Rendas-Baum, Regina
    Graham, Neil M. H.
    van Hoogstraten, Hubert
    Bayliss, Martha
    Fan, Chunpeng
    Huizinga, Tom
    Genovese, Mark C.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [33] Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial
    Strand, Vibeke
    Kremer, Joel M.
    Gruben, David
    Krishnaswami, Sriram
    Zwillich, Samuel H.
    Wallenstein, Gene V.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (04) : 592 - 598
  • [34] Improvements in patient reported outcomes over 24 weeks for rituximab with methotrexate in rheumatoid arthritis patients in the Dance R trial
    Mease, P. J.
    Szechinski, J.
    Greenwald, M.
    Leirisalo-Repo, M.
    Kivitz, A.
    Barile-Fabris, L.
    Kalsi, J.
    Eames, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 332 - 332
  • [35] Effect of Methotrexate Dose on the Efficacy of Tofacitinib: Treatment Outcomes from a Phase 3 Clinical Trial of Patients with Rheumatoid Arthritis
    Fleischmann, Roy
    Mease, Philip J.
    Schwartzman, Sergio
    Hwang, Lie-Ju
    Patel, Aditya
    Soma, Koshika
    Connell, Carol A.
    Takiya, Liza
    Bananis, Eustratios
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [36] EFFECT OF METHOTREXATE DOSE ON THE EFFICACY OF TOFACITINIB: TREATMENT OUTCOMES FROM A PHASE 3 CLINICAL TRIAL OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Fleischmann, R.
    Mease, P.
    Schwartzman, S.
    Hwang, L. -J.
    Soma, K.
    Connell, C.
    Takiya, L.
    Bananis, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 258 - 259
  • [37] RELATIONSHIP BETWEEN DIFFERENT CLINICAL MEASUREMENTS AND PATIENT-REPORTED OUTCOMES: RESULTS FROM A PHASE 3 STUDY OF TOFACITINIB OR METHOTREXATE IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS
    Fleischmann, R.
    Strand, V.
    Wilkinson, B.
    Kwok, K.
    Bananis, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 259 - 260
  • [38] Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial
    van Riel, P. L. C. M.
    Freundlich, B.
    MacPeek, D.
    Pedersen, R.
    Foehl, J. R.
    Singh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) : 1104 - 1110
  • [39] Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naive patients with rheumatoid arthritis
    Fleischmann, Roy
    Strand, Vibeke
    Wilkinson, Bethanie
    Kwok, Kenneth
    Bananis, Eustratios
    RMD OPEN, 2016, 2 (01):
  • [40] Comparative Analysis of Outcomes Among Patients with Rheumatoid Arthritis Initiating Tofacitinib in Combination with Oral Methotrexate (MTX) who Discontinue, Interrupt, or Persist with MTX
    Cohen, Stanley
    Haraoui, Boulos
    Curtis, Jeffrey
    Smith, Timothy
    Woolcott, John
    Gruben, David
    Murray, Christopher
    Iikuni, Noriko
    Koenig, Andrew
    Harnett, James
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 853 - 853
12345